According to foreign reports, a recent report shows that by 2025, the global market size of cannabis beverage is expected to reach 2.8 billion US dollars, with a compound annual growth rate of 17.8%. Grand view research reports on alcoholic and non-alcoholic beverages using cannabidiol (CBD) and THC.
By component, the market is subdivided into cannabis bisphenol (CBD) and tetrahydrocannabinol (THC). According to the report, the demand for cannabis drinks containing thc is mainly driven by the increased demand of adult consumers for recreational purposes. The increasing demand for the therapeutic effects of this ingredient, coupled with the excitement it brings, is expected to herald growth in this area in the next few years.
By contrast, cannabis drinks injected with CBD are the fastest growing (in previous years). In addition, demand is expected to surge during the forecast period due to the non psychoactive nature of CBD, according to the report. CBD drinks lack of psychoactive function and are expanding their use in medical applications.
Many consumers consider CBD beverage as a health and anti-inflammatory product, such as CommScope tea (a probiotic beverage). The beverage may be used to treat chronic pain, anxiety, drug use disorders and central nervous system diseases. It is expected that these factors will drive the adoption of products and thus the growth of the segment.